The endocannabinoid system as a therapeutic target for schizophrenia: failures and potentials. Seillier A. Neurosci Lett 2021 Jun 16:136064. doi: 10.1016/j.neulet.2021.136064.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Seillier A. The endocannabinoid system as a therapeutic target for schizophrenia: failures and potentials. Neurosci Lett 2021 Jun 16:136064. doi: 10.1016/j.neulet.2021.136064.
PMID: 34146641